Malignant Spinal Cord Compression Diagnosis and Treatment
Clinical Presentation
- The cardinal symptom of spinal cord compression is back pain, present in 90% of patients at presentation, though back pain alone is not predictive of malignant spinal cord compression (MSCC) 1
- Motor weakness and gait deterioration occur in approximately 67% of patients before diagnosis, with up to 50% of patients unable to walk at presentation 1
- Sensory changes including numbness, paresthesias, and sensory level deficits are common symptoms 1
- Autonomic dysfunction manifesting as bladder retention, bowel dysfunction, and sphincter disturbances occurs in 48% of patients 1
- Radicular pain extending from the spine along nerve root distributions is a symptom of spinal cord compression 1
Diagnostic Approach
- MRI of the entire spine is the preferred imaging modality and should be performed emergently for any patient with neurologic symptoms and a history of cancer 1
- MRI sensitivity is 0.44-0.93 and specificity is 0.90-0.98 1
- Myelography with CT is an alternative with sensitivity 0.71-0.97 and specificity 0.88-1.00 1
Treatment Algorithm
- High-dose dexamethasone should be initiated immediately upon clinical suspicion, even before radiographic confirmation, with a standard regimen of 96 mg IV daily, tapered over 14 days 2
- Surgery followed by radiotherapy is indicated for patients meeting specific criteria, including single level of compression, neurologic deficits present for <48 hours, predicted survival ≥3 months, and age <65 years 2, 3
- Absolute surgical indications regardless of other factors include bony retropulsion or bone fragments causing cord compression, frank spinal instability, and unknown primary requiring tissue diagnosis 2, 4
- Radiotherapy alone is the primary treatment for patients not meeting surgical criteria, with a standard regimen of 30 Gy in 10 fractions 2, 5
Prognostic Factors That Determine Outcomes
- Pretreatment ambulatory status is the single strongest predictor of post-treatment function and survival 4, 2
- Ambulatory patients have a 96-100% chance of remaining ambulatory after treatment, while paraparetic patients have only an 18-30% chance of regaining walking ability, and paraplegic patients have only a 2-6% chance 2
- Patients with slower motor deficit development (>14 days) have significantly better functional outcomes than those with rapid progression (<14 days, P<0.01) 6, 2
High-Risk Populations Requiring Vigilance
- Lung cancer, prostate cancer, and breast cancer account for 65% of MSCC episodes, with other high-risk malignancies including myeloma and renal cell carcinoma 6
- Asymptomatic patients with extensive bone metastases (>20 lesions) have a 32% risk of MSCC before hormone therapy and 44% after 24 months of treatment 6
Spinal Cord Compression Management
Diagnostic Approach
- Complete spine imaging is essential, not just the symptomatic level, as emphasized by the Journal of Clinical Oncology 7
Treatment Considerations
- Delaying treatment minimizes the chance of neurologic recovery—patients must be managed to minimize treatment delay, as highlighted by the Journal of Clinical Oncology 7
- The devastating natural history of untreated MSCC includes relentless pain, paralysis, sensory loss, and sphincter dysfunction, according to the Journal of Clinical Oncology 7
- Treatment decisions should consider pretreatment ambulatory status, comorbidities, technical surgical factors, presence of bony compression and spinal instability, potential surgical complications, potential radiotherapy reactions, and patient preferences, as recommended by the Journal of Clinical Oncology 7
Spinal Cord Compression Management
Clinical Presentation and Diagnostic Approach
- The American Society of Clinical Oncology recommends that patients with neurologic symptoms and a history of cancer should undergo MRI of the entire spine emergently 8
- Ambulatory patients without deficits do not require dexamethasone but need education about warning symptoms, as suggested by the Journal of Clinical Oncology 8
Prognostic Factors and Outcomes
- Pretreatment ambulatory status is the single strongest predictor of post-treatment function and survival, according to the Journal of Clinical Oncology 8
Adjunctive Management and Salvage Options
- The National Comprehensive Cancer Network suggests that patients with bone disease should be initiated on bone-directed therapy, and supportive treatments including analgesia, antiemetics, laxatives, and bladder care should be considered where appropriate 8
- Patients who deteriorate neurologically or recompress after radiotherapy should be considered for surgery, as recommended by the Journal of Clinical Oncology 8
- Patients who recompress in-field after radiotherapy may be considered for reirradiation, especially if it has been more than 6 weeks since completion of their last course, according to the Journal of Clinical Oncology 8
Clinical Presentation and Urgency of Spinal Cord Compression
Pain Manifestations
- Back pain is the cardinal symptom, occurring in roughly 90 % of individuals with spinal cord compression and often representing the first warning sign before any neurological deficits develop. 9
- Radicular pain may radiate along nerve‑root distributions in a dermatomal pattern, extending outward from the site of compression. 9
Motor Impairment
- At presentation, up to 50 % of patients are unable to walk because of lower‑extremity weakness caused by the compression. 9
Autonomic Dysfunction
- Bladder and bowel dysfunction are present in up to 50 % of patients at the time they first seek care. 9
- Sphincter dysfunction is explicitly included in the clinical definition of spinal cord compression. 9
Natural History Without Treatment
- If left untreated, spinal cord compression follows a relentless course leading to paralysis, complete sensory loss, and sphincter dysfunction. 9
Diagnostic Clues for Cauda Equina Syndrome
- Perianal or saddle‑area numbness is a characteristic finding of cauda equina syndrome, a specific form of spinal cord compression. 10
Dermatomal Correlation with Spinal Cord Compression Levels
Cervical Spine (C4‑C8)
- C5 compression produces sensory loss over the lateral arm. 11, 12
- C6 compression produces sensory loss over the lateral forearm and thumb. 11, 12
- C7 compression produces sensory loss over the middle finger. 11, 12
- C8 compression produces sensory loss over the medial forearm and little finger. 11, 12